Engineered Mesenchymal Stem Cell/Nanomedicine Spheroid as an Active Drug Delivery Platform for Combinational Glioblastoma Therapy-Reference-Cited by-同舟云学术

Engineered Mesenchymal Stem Cell/Nanomedicine Spheroid as an Active Drug Delivery Platform for Combinational Glioblastoma Therapy

Published:2019-02-18 Issue:3 Volume:19 Page:1701-1705
ISSN:1530-6984
Container-title:Nano Letters
language:en
Short-container-title:Nano Lett.

Author:

Suryaprakash Smruthi¹,Lao Yeh-Hsing¹,Cho Hyeon-Yeol²^ORCID,Li Mingqiang¹^ORCID,Ji Ha Yeun¹,Shao Dan¹,Hu Hanze¹^ORCID,Quek Chai Hoon¹,Huang Dantong¹,Mintz Rachel L.¹,Bagó Juli R.³,Hingtgen Shawn D.³,Lee Ki-Bum²,Leong Kam W.¹⁴^ORCID

Affiliation:

1. Department of Biomedical Engineering, Columbia University, New York, New York 10027, United States

2. Department of Chemistry and Chemical Biology, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, United States

3. Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

4. Department of Systems Biology, Columbia University Medical Center, New York, New York 10032, United States

Funder

National Institute of Allergy and Infectious Diseases

National Heart, Lung, and Blood Institute

National Center for Advancing Translational Sciences

U.S. Department of Defense

Publisher

American Chemical Society (ACS)

Subject

Mechanical Engineering,Condensed Matter Physics,General Materials Science,General Chemistry,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.nanolett.8b04697

Reference45 articles.

1. Stem and progenitor cell-mediated tumor selective gene therapy

2. Engineering mesenchymal stem cells for regenerative medicine and drug delivery

3. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy

4. Neural Stem Cell–Mediated Enzyme/Prodrug Therapy for Glioma: Preclinical Studies

5. ACTR-36. A PHASE I STUDY OF NEURAL STEM CELLS LOADED WITH AN ONCOLYTIC ADENOVIRUS FOR PATIENTS WITH NEWLY DIAGNOSED MALIGNANT GLIOMA: PRELIMINARY SAFETY AND DATA ANALYSIS

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spheroids in cancer research: Recent advances and opportunities;Journal of Drug Delivery Science and Technology;2024-10

2. Advances in tumor stroma-based targeted delivery;International Journal of Pharmaceutics;2024-10

3. Advancements in Engineering Planar Model Cell Membranes: Current Techniques, Applications, and Future Perspectives;Nanomaterials;2024-09-13

4. Propelling Minimally Invasive Tissue Regeneration With Next‐Era Injectable Pre‐Formed Scaffolds;Advanced Materials;2024-06-20

5. Non-Tumor Cells within the Tumor Microenvironment—The “Eminence Grise” of the Glioblastoma Pathogenesis and Potential Targets for Therapy;Cells;2024-05-09